Muskiet, M;
Wheeler, DC;
Heerspink, H;
(2019)
New pharmacological strategies for protecting kidney function in type 2 diabetes.
[Review].
The Lancet Diabetes and Endocrinology
, 7
(5)
pp. 397-412.
10.1016/S2213-8587(18)30263-8.
Preview |
Text
Wheeler_THELANCETDE-D-18-00382R1.pdf - Accepted Version Download (1MB) | Preview |
Abstract
Type 2 diabetes is the leading cause of impaired kidney function, albuminuria, and renal replacement therapy globally, thus placing a large burden on health-care systems. Current treatment strategies rely on intensive glucose lowering as well as strict blood pressure control through blockade of the renin–angiotensin–aldosterone system. Such approaches might slow decline in kidney function, but many patients progress to end-stage kidney failure despite optimal therapy. In recent clinical trials, new-generation glucose-lowering drug classes, the sodium-glucose co-transporter-2 inhibitors and agents that target the incretin pathway, have been shown to improve kidney outcomes in patients with type 2 diabetes. Other new approaches, which have been developed on the basis of an improved understanding of the mechanisms that contribute to kidney damage in the context of diabetes, include use of drugs that block endothelin receptors (eg, atrasentan) and non-steroidal mineralocorticoid receptors (eg, finerenone). In this Review, we provide an overview of recent clinical data relevant to these new therapeutic approaches for management of kidney disease in the context of type 2 diabetes.
| Type: | Article |
|---|---|
| Title: | New pharmacological strategies for protecting kidney function in type 2 diabetes |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/S2213-8587(18)30263-8 |
| Publisher version: | https://doi.org/10.1016/S2213-8587(18)30263-8 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Renal Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10054748 |
Loading...
Loading...Loading...Loading...Archive Staff Only
 |
View Item |
